Phenylethylidenehydrazine
Metabolite of an antidepressant drug
From Wikipedia, the free encyclopedia
Phenylethylidenehydrazine (PEH), also known as 2-phenylethylhydrazone or as β-phenylethylidenehydrazine, is a GABA transaminase inhibitor.[1][2] It is a metabolite of the antidepressant phenelzine and is responsible for its elevation of GABA concentrations.[1] PEH may contribute to phenelzine's anxiolytic effects.[3]
| |
| Clinical data | |
|---|---|
| Drug class | GABA-T inhibitor |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Elimination half-life | ~12 hours[citation needed] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C8H10N2 |
| Molar mass | 134.182 g·mol−1 |
| 3D model (JSmol) | |
| |
